Sanofi-Aventis has reached an agreement to buy Merck’s 50 percent stake in animal health joint venture Merial Limited for $4 billion in cash.
Established in 1997, Merial manufacturers vaccines for pets, livestock and wildlife, including the FRONTLINE brand of flea and tick control. It has approximately 5,400 employees in 150 countries and recorded $2.8 billion in sales last year.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
